1003-3734
2009 Issue 21
Anti-tumor efficacy of lidamycin in combination with chemotherapeutic drugs
shang bo-yang; wu shu-ying; shang yue; li dian-dong; zhen yong-su (institute of medicinal biotechnology; chinese academy of medical sciences and peking union medical college; beijing 100050; china)
shang bo-yang; wu shu-ying; shang yue; li dian-dong; zhen yong-su (institute of medicinal biotechnology; chinese academy of medical sciences and peking union medical college; beijing 100050; china)
..............page:2075-2080
Challenges in reform of Chinese medical and health system:a deep thinking
song rui-lin; zhang zheng-guang (research center on medicinal policy under chinese pharmaceutical association; beijing 100022; china)
song rui-lin; zhang zheng-guang (research center on medicinal policy under chinese pharmaceutical association; beijing 100022; china)
..............page:2014-2019
Investigation on pharmacokinetics of tilidine
sun li1; 2; ouyang jin1; deng yan-ping2 (1 chemistry college; beijing normal university; beijing 100875; china; 2 national institute on drug dependence; peking university; beijing 100191; china)
sun li1; 2; ouyang jin1; deng yan-ping2 (1 chemistry college; beijing normal university; beijing 100875; china; 2 national institute on drug dependence; peking university; beijing 100191; china)
..............page:2043-2046,2051
A novel therapeutic disaccharide for Huntington's disease by inhibiting aggregation and delaying pathology
li zhao-hua1; meng jian-zong2; zhou li-yuan3; dong xian-zhi1 (1 protein & peptide pharmaceutical laboratory; institute of biophysics of chinese academy of sciences; beijing 100101; china; 2 college of life science and technology; guangxi university; nanning 530004; china; 3 the people s hospital of guangxi zhuang autonomous region; nanning 530021; china)
li zhao-hua1; meng jian-zong2; zhou li-yuan3; dong xian-zhi1 (1 protein & peptide pharmaceutical laboratory; institute of biophysics of chinese academy of sciences; beijing 100101; china; 2 college of life science and technology; guangxi university; nanning 530004; china; 3 the people s hospital of guangxi zhuang autonomous region; nanning 530021; china)
..............page:2032-2035
Progress of kinesin spindle protein inhibitors
zhang yan; liu xiao; wang ru-bing; fu wei; li zhi-yu (department of medicinal chemistry; china pharmaceutical university; nanjing 210009; china)
zhang yan; liu xiao; wang ru-bing; fu wei; li zhi-yu (department of medicinal chemistry; china pharmaceutical university; nanjing 210009; china)
..............page:2036-2042
Evaluation for developmental toxicity of rhodioside injection in rats
zhu yu-ping; zhu jiang-bo; ma xi-li; tian yi-jun; wan xu-ying; zhang tian-bao (department of toxicology; second military medical university; shanghai 200433; china)
zhu yu-ping; zhu jiang-bo; ma xi-li; tian yi-jun; wan xu-ying; zhang tian-bao (department of toxicology; second military medical university; shanghai 200433; china)
..............page:2068-2071
..............page:2009-2010
Preliminary evaluation of brain targeting via intranasal administration of galanthamine hydrobromide
han xiao-lin1; chen xiao1; yu shan-jiang2; yu shao-yun1 (1 college of life science and technology; beijing university of chemical technology; beijing 100029; china; 2 china national center for biotechnology development; beijing 100081; china)
han xiao-lin1; chen xiao1; yu shan-jiang2; yu shao-yun1 (1 college of life science and technology; beijing university of chemical technology; beijing 100029; china; 2 china national center for biotechnology development; beijing 100081; china)
..............page:2084-2088
Adverse reactions and rational uses of selective serotonin reuptake inhibitors
qin ji-hong; zhao hui; li zhong-dong (department of pharmacy; general hospital of air force; beijing 100036; china)
qin ji-hong; zhao hui; li zhong-dong (department of pharmacy; general hospital of air force; beijing 100036; china)
..............page:2093-2095
Determination of the concentration of perospirone hydrochloride by RP-HPLC
liu cui1; huang min-jiang2; yang lun3 (1 zhongshan dosage of the united laboratories company ltd.; zhongshan 528467; china; 2 livzon syntpharm company ltd.; zhuhai 519030; china; 3 the institute of livzon pharmaceutical group inc.; zhuhai 519020; china)
liu cui1; huang min-jiang2; yang lun3 (1 zhongshan dosage of the united laboratories company ltd.; zhongshan 528467; china; 2 livzon syntpharm company ltd.; zhuhai 519030; china; 3 the institute of livzon pharmaceutical group inc.; zhuhai 519020; china)
..............page:2089-2092
New synthesis process of salmeterol xinafoate
wang xiao-qin; wang qin; he ming-hua (department of medicinal chemistry and pharm-analysis; guangdong medical university; dongguan 523808; china)
wang xiao-qin; wang qin; he ming-hua (department of medicinal chemistry and pharm-analysis; guangdong medical university; dongguan 523808; china)
..............page:2081-2083
Placebo controlled clinical trial of Chanyeanshen capsules in insomnia patients
lian feng-mei1; xu gui-cheng2; liu kun2; liu zong-lian2; wang qiu-feng2; qiu ping2; yu chun-yan2; yin yi-jian2; li ning2; gao lin2 (1 department of drug clinical trial institution; 2 department of general medicine; guang anmen hospital; china academy of chinese medicine science; beijing 100053; china)
lian feng-mei1; xu gui-cheng2; liu kun2; liu zong-lian2; wang qiu-feng2; qiu ping2; yu chun-yan2; yin yi-jian2; li ning2; gao lin2 (1 department of drug clinical trial institution; 2 department of general medicine; guang anmen hospital; china academy of chinese medicine science; beijing 100053; china)
..............page:2056-2060
Protection of scutellarein on cerebral ischemia in rats
song yan; zhang hong-mei; ma jian-jian; che qing-ming; li chang-ling (school of pharmaceutical sciences; peking university; beijing 100191; china)
song yan; zhang hong-mei; ma jian-jian; che qing-ming; li chang-ling (school of pharmaceutical sciences; peking university; beijing 100191; china)
..............page:2061-2064
..............page:2067
..............page:2008
Advance in the pharmacological study of rimonabant
yuan ye; wu chun-qi; liao ming-yang (institute of pharmacology and toxicology; academy of military medical sciences; beijing 100850; china)
yuan ye; wu chun-qi; liao ming-yang (institute of pharmacology and toxicology; academy of military medical sciences; beijing 100850; china)
..............page:2028-2031,2092
kang yi yu xin yao you xin ding jiao nang de yan zhi xiang mu jie shao
wang yu qin ; ge qiang ; chen wei dong ; xu chang jiang ; jia wei guo
wang yu qin ; ge qiang ; chen wei dong ; xu chang jiang ; jia wei guo
..............page:2027
Effect of Haizhumingmu eye drops on cataract in rats
zou xian-gang1; liang zu-zhen1; lin xing2; huang jian-chun2; huang ren-bin2; jiang ming-lian3 (1 beihai blue ocean bio-pharmaceutical co.; ltd; beihai 536000; china; 2 department of pharmacology; guangxi medical university; nanning 530021; china; 3 nanning institute for food and drug control; guangxi zhuang autonomous region; nanning 530022; china)
zou xian-gang1; liang zu-zhen1; lin xing2; huang jian-chun2; huang ren-bin2; jiang ming-lian3 (1 beihai blue ocean bio-pharmaceutical co.; ltd; beihai 536000; china; 2 department of pharmacology; guangxi medical university; nanning 530021; china; 3 nanning institute for food and drug control; guangxi zhuang autonomous region; nanning 530022; china)
..............page:2072-2074
Effect of lipoic acid on Aβ1-42-induced damage in PC12 cells
wei wen-qing; liu jing; zhang yan; fu yao; jiao juan; zhao man-cang (department of central laboratory; general hospital of beijing military command; beijing 100700; china)
wei wen-qing; liu jing; zhang yan; fu yao; jiao juan; zhao man-cang (department of central laboratory; general hospital of beijing military command; beijing 100700; china)
..............page:2065-2067
Clinical efficacy of paliperidone controlled release tablets and its influence on serum prolactin level in patients with acute schizophrenia
wang zong-qin; wang gao-hua; wang hui-ling; wang xiao-ping (people s hospital; wuhan university; wuhan 430060; china)
wang zong-qin; wang gao-hua; wang hui-ling; wang xiao-ping (people s hospital; wuhan university; wuhan 430060; china)
..............page:2052-2055
Advance in studies of acute drug toxicity
wang qing-li; wang hai-xue; ma lei (center for drug evaluation; state food and drug administration; beijing 100038; china)
wang qing-li; wang hai-xue; ma lei (center for drug evaluation; state food and drug administration; beijing 100038; china)
..............page:2024-2027
Carisbamate,a novel antiepleptic drug
xu jia-jun; liu xiao-yan (department of pharmacy; renji hospital; medical school of shanghai jiaotong university; shanghai 200127; china)
xu jia-jun; liu xiao-yan (department of pharmacy; renji hospital; medical school of shanghai jiaotong university; shanghai 200127; china)
..............page:2011-2013
Phase Ⅲ clinical trial of adefovir dipivoxil capsule in patients with HBeAg positive chronic hepatitis B
zhang hao-ye1; gong huan-yu1; yang guo-ping1; li yue-qi2; wang mao-rong3; huang wen-xiang4; sun zhen-qiu5 (1 the third xiangya hospital of central south university; changsha 410013; china; 2 302 military hospital of china; beijing 100039; china; 3 81 military hospital of china; nanjing 210002; china; 4 the first affiliated hospital of chongqing medical university; chongqing 400016; china; 5 center for health information and health management of central south university; changsha 410008; china)
zhang hao-ye1; gong huan-yu1; yang guo-ping1; li yue-qi2; wang mao-rong3; huang wen-xiang4; sun zhen-qiu5 (1 the third xiangya hospital of central south university; changsha 410013; china; 2 302 military hospital of china; beijing 100039; china; 3 81 military hospital of china; nanjing 210002; china; 4 the first affiliated hospital of chongqing medical university; chongqing 400016; china; 5 center for health information and health management of central south university; changsha 410008; china)
..............page:2047-2051
Types and main points of site inspections of drug clinical trial institutions in China
xie qin; song shu-fen (center for certification of drug; state food and drug administration; beijing 100061; china)
xie qin; song shu-fen (center for certification of drug; state food and drug administration; beijing 100061; china)
..............page:2020-2023
..............page:2096